SecBot SecBot
DEFA14A ·Filed Mar 23, 2026

ABBV

AbbVie Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed7mo ago SEC0001104659-26-033391
Proxy solicitation materials
Actionable Insight • Neutral

This is a standard proxy filing for an annual shareholder meeting. No immediate trading action is required. Monitor the voting results for the shareholder proposal on an independent chair, as a significant vote could signal governance concerns.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$203.51
T+0 close · Mar 23, 2026 · via day close
Latest settled
+6.38%
T+60 · $216.49
Vs SPY
−7.95%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 24 $203.51entry
  2. T+1 · 8mo ago +0.96%α +0.40% · $205.48
  3. T+5 · 8mo ago +5.99%α +6.41% · $215.70
  4. T+20 · 7mo ago −1.48%α −10.38% · $200.50
  5. T+60 · 5mo ago +6.38%α −7.95% · $216.49
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

AbbVie Inc. is holding its 2026 Annual Meeting for shareholders. The proxy statement includes proposals to elect four Class II directors, ratify the independent auditor, approve executive compensation (Say on Pay), amend the certificate of incorporation to eliminate supermajority voting, and vote on a shareholder proposal to adopt an independent chair. This is routine corporate governance material.

Key Facts

  • Annual meeting scheduled for May 8, 2026.
  • Four Class II directors are up for election: Jennifer L. Davis, Melody B. Meyer, Robert A. Michael, and Frederick H. Waddell.
  • Proposal to ratify Ernst & Young LLP as the independent auditor for 2026.
  • Say on Pay advisory vote on executive compensation.
  • Management proposal to amend the certificate of incorporation to eliminate supermajority voting.
  • Shareholder proposal to adopt a policy requiring an independent chair.

Financial Impact

No direct financial impact from this filing.

Risk Factors

  • A significant vote against management on the independent chair proposal could indicate shareholder dissatisfaction with current governance, potentially leading to future governance changes or activist pressure.

Market Snapshot

Price
$204.91
Volume
100
Exchange
NYSE
Analyst Consensus
69% bullish (39 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001104659-26-033391
Document: 0001104659-26-033391-index-headers.html0001104659-26-033391
Document: 0001104659-26-033391-index.html0001104659-26-033391
Document: 0001104659-26-033391.txt0001104659-26-033391

US Market Status

Market Closed · Opens Tue (16h 40m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 23, 2026